Literature DB >> 27252749

Atypical femoral fractures bilaterally in a patient receiving bisphosphonate: a case report.

Alessandro Moghnie1, Veronica Scamacca1, Giovanni De Fabrizio1, Roberto Valentini1.   

Abstract

Atypical femoral fractures are often associated with prolonged bisphosphonate use. The American Society for Bone and Mineral Research (ASBMR) has set the diagnosis criteria for atypical subtrochanteric and diaphyseal femoral fractures by classifying them according to their major and minor criteria. Prolonged bisphosphonate use is correlated with AFF, but the pathogenetic mechanism that causes this kind of fracture has not been defined yet. We describe simultaneous bilaterally femoral fractures in a 76-year-old woman.

Entities:  

Keywords:  atypical femoral fracture

Year:  2016        PMID： 27252749      PMCID： PMC4869959          DOI： 10.11138/ccmbm/2016.13.1.057

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN： 1724-8914


  8 in total

Review 1.  Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis.

Authors:  Lydia Gedmintas; Daniel H Solomon; Seoyoung C Kim
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

2.  Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.

Authors:  Raphael P H Meier; Thomas V Perneger; Richard Stern; René Rizzoli; Robin E Peter
Journal:  Arch Intern Med       Date:  2012-06-25

3.  Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study.

Authors:  Douglas C Bauer; Ann Schwartz; Lisa Palermo; Jane Cauley; Marc Hochberg; Art Santora; Steven R Cummings; Dennis M Black
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

4.  Atypical femoral fractures.

Authors:  Sandro Giannini; Eugenio Chiarello; Giuseppe Tedesco; Matteo Cadossi; Deianira Luciani; Antonio Mazzotti; Davide Maria Donati
Journal:  Clin Cases Miner Bone Metab       Date:  2013-01

5.  Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Peter R Ebeling; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David Dempster; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Kenneth Koval; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Howe Tet Sen; Marjolein C H van der Meulen; Robert S Weinstein; Michael Whyte
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

Review 6.  Atypical femoral fractures: a review of the literature.

Authors:  Pingal A Desai; Parth A Vyas; Joseph M Lane
Journal:  Curr Osteoporos Rep       Date:  2013-09       Impact factor: 5.096

7.  The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate.

Authors:  Devendra Bajaj; Joseph R Geissler; Matthew R Allen; David B Burr; J C Fritton
Journal:  Bone       Date:  2014-04-01       Impact factor: 4.398

8.  Atypical femoral fractures bilaterally in a patient receiving denosumab.

Authors:  Efstathios Drampalos; George Skarpas; Nikos Barbounakis; Ioannis Michos
Journal:  Acta Orthop       Date:  2013-10-31       Impact factor: 3.717
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.